Funding Applications
Funding applictions are made to PHARMAC. If PHARMAC considers that clinical advice on the Application is required, the first step in the assessment process will be a review of the Application by the Pharmacology and Therapeutics Advisory Committee (PTAC) or, in some cases, one of the specialist PTAC Subcommittees.
Funding applications can be made by pharmaceutical suppliers, health professionals, consumer groups and individuals. Guidelines for making these submissions are available here:
Guidelines for Funding Applications to PHARMAC 2010 (52 pages, 2224 KB)
Recommended methods to derive clinical inputs for proposals to PHARMAC (37 pages, 332 KB)
2011 PTAC meetings and funding application timelines (2 pages, 218 KB)
2010 PTAC meetings and funding application timelines (2 pages, 225 KB)
New Funding Applications
Funding Applications which will be considered at the November PTAC meeting are listed below:
- Paracetamol and ibuprofen (Maxigesic) for analgesia and fever reduction. AFT Pharmaceuticals; submitted 4/08/2010
- Lapatinib for HER2 positive metastatic breast cancer. New Zealand Breast Cancer Special Interest Group; submitted 21/07/2010
- Rifabutin for H. pylori. Individual; submitted 27/07/2010
- Bortezomib for AL amyloidosis. Individual; submitted 16/07/2010
- Imiglucerase for Gaucher's disease. Individual; submitted 6/07/2010
- Miglustat (Zavesca) for type 1 Gaucher's disease; Actelion; submitted 17/08/2010
- Fluticasone propionate/salmeterol xinafoate (Seretide) for asthma. Glaxo Smith Kline; submitted 17/08/2010
- Adalimumab (Humira) for juvenile idiopathic arthritis. Abbott; submitted 17/08/2010
- Posaconazole (Noxafil) for aspergillus. Merck Sharp & Dohme; Submitted 17/08/2010
- Nab-Paclitaxel (Abraxane) for advanced breast cancer. Specialised Therapeutics; submitted 17/08/2010
- Dabigatran (Pradaxa) for stroke, systemic embolism, and atrial fibrillation. Boehringer Ingelheim; submitted 25/05/2010
Historic Funding Applications
A list of applications received for new investments since 1 December 2008 is available here (7 pages, 81 KB)
A list of applications received for new investments between 1 July 2002 and 30 November 2008 is available here (19 pages, 107 KB).
Page updated on 02 Sep 2010
Linked documents
Guidelines for Funding Applications to PHARMAC 2010 (52 pages, 2224 KB)
Guidelines for Funding Applications to PHARMAC Version 2 2009 Foreword PHARMAC, the Pharmaceutical Management Agency, is primarily responsible for managing the funding of community pharmaceuticals for New Zealanders, on behalf of the District Health Boards. PHARMAC’s objective is to secure,…
Recommended methods to derive clinical inputs for proposals to PHARMAC (37 pages, 332 KB)
Recommended methods to derive clinical inputs for proposals to PHARMAC Version 1B 20 July 2005 R8-0-0 #62465 Table of contents Recommended methods to derive clinical inputs for proposals to PHARMAC ….. 1 Table of contents… 2 Context of these recommendations…
2011 PTAC meeting dates and application timeline (2 pages, 218 KB)
3 August 2010 Dear Pharmaceutical Suppliers 2011 PTAC meetings and funding application timelines Please find below the 2011 dates for the Pharmacology and Therapeutics Advisory Committee (PTAC) meetings, and the last possible dates for receipt of funding applications that allow…
2010 PTAC timelines for meetings (2 pages, 225 KB)
28 January 2009 Dear Pharmaceutical Suppliers 2010 PTAC meetings and funding application timelines Please find below the 2010 dates for the Pharmacology and Therapeutics Advisory Committee (PTAC) meetings, and the last possible dates for receipt of funding…
Applications received since 1 November 2008 (7 pages, 81 KB)
Applications received for new investments since 1 November 2008 Details of Funding Applications received are published on PHARMAC’s website, in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Applications Received…
Applications received since 1 July 2002 (19 pages, 107 KB)
Applications received for new investments since 1 July 2002: As published in the Guidelines for the Pharmacology and Therapeutics Advisory Committee (PTAC) and its Subcommittees 2002, PHARMAC is, from 1 July 2002, making the existence of applications for new investments…
